Figma Insiders Buy Amid Steep Decline, but AI Monetization Risks Dominate

What happened

Figma's stock has tanked over 70% since its IPO peak, trading around $30 amid fears of AI disrupting its business model and compressing margins. Insider activity in late February 2026 shows director Reed Andrew Phillips purchasing over 1.4 million shares, while CEO Field Dylan executed stock conversions and sales, suggesting mixed signals from leadership. The DeepValue report emphasizes a critical near-term catalyst: starting March 2026, Figma enforces AI credit limits with paid top-ups, a high-stakes experiment testing pricing power versus customer pushback. Despite strong historical metrics like 136% net dollar retention, filings explicitly warn of risks including churn, seat reductions from AI efficiency, and ongoing gross margin pressure from infrastructure costs. Investors should view insider buying with skepticism, as it does not address the fundamental uncertainties around AI monetization that could make or break the stock's recovery.

Implication

For investors, the insider purchases, particularly by a director, indicate belief in a rebound, yet they occur against a backdrop of operational uncertainty as Figma shifts its revenue model. The enforcement of AI credit limits starting March 2026 is a binary event that could either lift average revenue per user or trigger customer dissatisfaction, churn, and margin deterioration, directly impacting valuation. Monitoring post-implementation data on net dollar retention and gross margin will be essential, as declines could validate bear scenarios and push the stock toward the $22 downside target. While strong liquidity with $1.7 billion in cash provides a buffer, the current valuation at 11x FY2026 revenue remains elevated if growth slows or profitability fails to materialize. Therefore, maintaining a cautious stance and awaiting clarity from the AI credit experiment is prudent, as insider optimism alone cannot offset the structural risks highlighted in regulatory filings.

Thesis delta

The news of insider buying does not shift the core investment thesis from the DeepValue report, which remains a 'WAIT' rating focused on the outcome of AI monetization. It highlights the stock's volatility and the contrast between internal confidence and external skepticism, but fundamental risks around customer retention and margins are unchanged. Investors should prioritize observable metrics from the March 2026 rollout over insider sentiment, as filings caution against over-optimism given the potential for negative outcomes.